Lipovelutibol A
| Internal ID | a3872062-46e6-457e-9bbb-383abd17d83d |
| Taxonomy | Organic acids and derivatives > Carboxylic acids and derivatives > Amino acids, peptides, and analogues > Peptides |
| IUPAC Name | (2S)-2-[[(2S,3S)-2-[[(2S)-3-hydroxy-2-[[2-methyl-2-[[(2S)-4-methyl-2-[[(2S)-2-[[2-(octanoylamino)acetyl]amino]propanoyl]amino]pentanoyl]amino]propanoyl]amino]propanoyl]amino]-3-methylpentanoyl]amino]-4-methylpentanoic acid |
| SMILES (Canonical) | |
| SMILES (Isomeric) | |
| InChI | InChI=1S/C38H69N7O10/c1-11-13-14-15-16-17-29(47)39-20-30(48)40-25(8)32(49)41-26(18-22(3)4)34(51)45-38(9,10)37(55)43-28(21-46)33(50)44-31(24(7)12-2)35(52)42-27(36(53)54)19-23(5)6/h22-28,31,46H,11-21H2,1-10H3,(H,39,47)(H,40,48)(H,41,49)(H,42,52)(H,43,55)(H,44,50)(H,45,51)(H,53,54)/t24-,25-,26-,27-,28-,31-/m0/s1 |
| InChI Key | RXBPMQROEPWYAU-POOCDACNSA-N |
| Popularity | 2 references in papers |
| Molecular Formula | C38H69N7O10 |
| Molecular Weight | 784.00 g/mol |
| Exact Mass | 783.51059142 g/mol |
| Topological Polar Surface Area (TPSA) | 261.00 Ų |
| XlogP | 3.70 |
| Atomic LogP (AlogP) | 1.02 |
| H-Bond Acceptor | 9 |
| H-Bond Donor | 9 |
| Rotatable Bonds | 27 |
| (2S)-2-[[(2S,3S)-2-[[(2S)-3-hydroxy-2-[[2-methyl-2-[[(2S)-4-methyl-2-[[(2S)-2-[[2-(octanoylamino)acetyl]amino]propanoyl]amino]pentanoyl]amino]propanoyl]amino]propanoyl]amino]-3-methylpentanoyl]amino]-4-methylpentanoic acid |
| (2S)-2-(((2S,3S)-2-(((2S)-1,3-dihydroxy-2-((1-hydroxy-2-(((2S)-1-hydroxy-2-(((2S)-1-hydroxy-2-((1-hydroxy-2-((1-hydroxyoctylidene)amino)ethylidene)amino)propylidene)amino)-4-methylpentylidene)amino)-2-methylpropylidene)amino)propylidene)amino)-1-hydroxy-3-methylpentylidene)amino)-4-methylpentanoate |
| (2S)-2-(((2S,3S)-2-(((2S)-3-hydroxy-2-((2-methyl-2-(((2S)-4-methyl-2-(((2S)-2-((2-(octanoylamino)acetyl)amino)propanoyl)amino)pentanoyl)amino)propanoyl)amino)propanoyl)amino)-3-methylpentanoyl)amino)-4-methylpentanoic acid |
| (2S)-2-{[(2S,3S)-2-{[(2S)-1,3-dihydroxy-2-[(1-hydroxy-2-{[(2S)-1-hydroxy-2-{[(2S)-1-hydroxy-2-({1-hydroxy-2-[(1-hydroxyoctylidene)amino]ethylidene}amino)propylidene]amino}-4-methylpentylidene]amino}-2-methylpropylidene)amino]propylidene]amino}-1-hydroxy-3-methylpentylidene]amino}-4-methylpentanoate |
| RefChem:153625 |
| CHEBI:208816 |
| Target | Value | Probability (raw) | Probability (%) |
|---|---|---|---|
| Human Intestinal Absorption | + | 0.6656 | 66.56% |
| Caco-2 | - | 0.8573 | 85.73% |
| Blood Brain Barrier | + | 0.6000 | 60.00% |
| Human oral bioavailability | - | 0.7714 | 77.14% |
| Subcellular localzation | Mitochondria | 0.5919 | 59.19% |
| OATP2B1 inhibitior | - | 0.5803 | 58.03% |
| OATP1B1 inhibitior | + | 0.8407 | 84.07% |
| OATP1B3 inhibitior | + | 0.9265 | 92.65% |
| MATE1 inhibitior | - | 0.9800 | 98.00% |
| OCT2 inhibitior | - | 0.9250 | 92.50% |
| BSEP inhibitior | + | 0.8436 | 84.36% |
| P-glycoprotein inhibitior | + | 0.7342 | 73.42% |
| P-glycoprotein substrate | + | 0.7609 | 76.09% |
| CYP3A4 substrate | + | 0.6498 | 64.98% |
| CYP2C9 substrate | + | 0.6356 | 63.56% |
| CYP2D6 substrate | - | 0.8737 | 87.37% |
| CYP3A4 inhibition | - | 0.8397 | 83.97% |
| CYP2C9 inhibition | - | 0.8922 | 89.22% |
| CYP2C19 inhibition | - | 0.8606 | 86.06% |
| CYP2D6 inhibition | - | 0.8816 | 88.16% |
| CYP1A2 inhibition | - | 0.8919 | 89.19% |
| CYP2C8 inhibition | - | 0.5663 | 56.63% |
| CYP inhibitory promiscuity | - | 0.9400 | 94.00% |
| UGT catelyzed | + | 0.7000 | 70.00% |
| Carcinogenicity (binary) | - | 0.8500 | 85.00% |
| Carcinogenicity (trinary) | Non-required | 0.6356 | 63.56% |
| Eye corrosion | - | 0.9745 | 97.45% |
| Eye irritation | - | 0.9020 | 90.20% |
| Skin irritation | - | 0.8472 | 84.72% |
| Skin corrosion | - | 0.9732 | 97.32% |
| Ames mutagenesis | - | 0.8900 | 89.00% |
| Human Ether-a-go-go-Related Gene inhibition | - | 0.4862 | 48.62% |
| Micronuclear | + | 0.5300 | 53.00% |
| Hepatotoxicity | + | 0.5316 | 53.16% |
| skin sensitisation | - | 0.8630 | 86.30% |
| Respiratory toxicity | - | 0.5111 | 51.11% |
| Reproductive toxicity | - | 0.6608 | 66.08% |
| Mitochondrial toxicity | - | 0.7375 | 73.75% |
| Nephrotoxicity | + | 0.5115 | 51.15% |
| Acute Oral Toxicity (c) | III | 0.6717 | 67.17% |
| Estrogen receptor binding | + | 0.7814 | 78.14% |
| Androgen receptor binding | + | 0.5976 | 59.76% |
| Thyroid receptor binding | + | 0.5399 | 53.99% |
| Glucocorticoid receptor binding | + | 0.5799 | 57.99% |
| Aromatase binding | + | 0.6745 | 67.45% |
| PPAR gamma | + | 0.6778 | 67.78% |
| Honey bee toxicity | - | 0.8897 | 88.97% |
| Biodegradation | - | 0.9000 | 90.00% |
| Crustacea aquatic toxicity | + | 0.5969 | 59.69% |
| Fish aquatic toxicity | + | 0.7508 | 75.08% |
Proven Targets:
| CHEMBL ID | UniProt ID | Name | Min activity | Assay type | Source |
|---|---|---|---|---|---|
| No proven targets yet! | |||||
Predicted Targets (via Super-PRED):
| CHEMBL ID | UniProt ID | Name | Probability | Model accuracy |
|---|---|---|---|---|
| CHEMBL230 | P35354 | Cyclooxygenase-2 | 99.94% | 89.63% |
| CHEMBL2581 | P07339 | Cathepsin D | 99.88% | 98.95% |
| CHEMBL3837 | P07711 | Cathepsin L | 99.22% | 96.61% |
| CHEMBL3359 | P21462 | Formyl peptide receptor 1 | 98.98% | 93.56% |
| CHEMBL3892 | Q99500 | Sphingosine 1-phosphate receptor Edg-3 | 98.15% | 97.29% |
| CHEMBL3060 | Q9Y345 | Glycine transporter 2 | 97.90% | 99.17% |
| CHEMBL1907591 | P30926 | Neuronal acetylcholine receptor; alpha4/beta4 | 97.55% | 100.00% |
| CHEMBL4018 | P49146 | Neuropeptide Y receptor type 2 | 96.56% | 98.94% |
| CHEMBL236 | P41143 | Delta opioid receptor | 95.51% | 99.35% |
| CHEMBL1907594 | P30926 | Neuronal acetylcholine receptor; alpha3/beta4 | 95.28% | 97.23% |
| CHEMBL2514 | O95665 | Neurotensin receptor 2 | 94.71% | 100.00% |
| CHEMBL221 | P23219 | Cyclooxygenase-1 | 93.37% | 90.17% |
| CHEMBL5285 | Q99683 | Mitogen-activated protein kinase kinase kinase 5 | 93.22% | 92.26% |
| CHEMBL299 | P17252 | Protein kinase C alpha | 93.17% | 98.03% |
| CHEMBL5701 | Q9H2K8 | Serine/threonine-protein kinase TAO3 | 93.04% | 96.67% |
| CHEMBL4227 | P25090 | Lipoxin A4 receptor | 92.53% | 100.00% |
| CHEMBL3176 | O43603 | Galanin receptor 2 | 92.14% | 98.89% |
| CHEMBL5261 | Q7L7X3 | Serine/threonine-protein kinase TAO1 | 91.86% | 89.33% |
| CHEMBL2955 | O95136 | Sphingosine 1-phosphate receptor Edg-5 | 91.79% | 92.86% |
| CHEMBL3130 | O00329 | PI3-kinase p110-delta subunit | 91.40% | 96.47% |
| CHEMBL4769 | O95749 | Geranylgeranyl pyrophosphate synthetase | 91.18% | 92.08% |
| CHEMBL5966 | P55899 | IgG receptor FcRn large subunit p51 | 90.73% | 90.93% |
| CHEMBL3251 | P19838 | Nuclear factor NF-kappa-B p105 subunit | 90.38% | 96.09% |
| CHEMBL3776 | Q14790 | Caspase-8 | 90.33% | 97.06% |
| CHEMBL2265 | P23141 | Acyl coenzyme A:cholesterol acyltransferase | 90.24% | 85.94% |
| CHEMBL5979 | P05186 | Alkaline phosphatase, tissue-nonspecific isozyme | 90.04% | 85.40% |
| CHEMBL1907605 | P24864 | Cyclin-dependent kinase 2/cyclin E1 | 89.99% | 92.88% |
| CHEMBL260 | Q16539 | MAP kinase p38 alpha | 89.66% | 97.78% |
| CHEMBL4793 | Q86TI2 | Dipeptidyl peptidase IX | 89.64% | 96.95% |
| CHEMBL335 | P18031 | Protein-tyrosine phosphatase 1B | 89.35% | 95.17% |
| CHEMBL4657 | Q6V1X1 | Dipeptidyl peptidase VIII | 89.16% | 97.21% |
| CHEMBL1795139 | Q8IU80 | Transmembrane protease serine 6 | 88.66% | 98.33% |
| CHEMBL5043 | Q6P179 | Endoplasmic reticulum aminopeptidase 2 | 88.27% | 91.81% |
| CHEMBL2179 | P04062 | Beta-glucocerebrosidase | 88.02% | 85.31% |
| CHEMBL1075094 | Q16236 | Nuclear factor erythroid 2-related factor 2 | 86.80% | 96.00% |
| CHEMBL2996 | Q05655 | Protein kinase C delta | 86.78% | 97.79% |
| CHEMBL3468 | P55210 | Caspase-7 | 86.67% | 95.68% |
| CHEMBL3308 | P55212 | Caspase-6 | 85.31% | 97.56% |
| CHEMBL268 | P43235 | Cathepsin K | 84.77% | 96.85% |
| CHEMBL2274 | Q9H228 | Sphingosine 1-phosphate receptor Edg-8 | 84.07% | 100.00% |
| CHEMBL4662 | P28074 | Proteasome Macropain subunit MB1 | 84.05% | 93.85% |
| CHEMBL259 | P32245 | Melanocortin receptor 4 | 83.93% | 95.38% |
| CHEMBL2095164 | P49354 | Geranylgeranyl transferase type I | 83.77% | 92.80% |
| CHEMBL3267 | P48736 | PI3-kinase p110-gamma subunit | 83.48% | 95.71% |
| CHEMBL5163 | Q9NY46 | Sodium channel protein type III alpha subunit | 83.29% | 96.90% |
| CHEMBL1781 | P11387 | DNA topoisomerase I | 83.08% | 97.00% |
| CHEMBL4123 | P30989 | Neurotensin receptor 1 | 82.97% | 96.67% |
| CHEMBL2664 | P23526 | Adenosylhomocysteinase | 82.77% | 86.67% |
| CHEMBL3238 | P23786 | Carnitine palmitoyltransferase 2 | 82.64% | 94.05% |
| CHEMBL5619 | P27695 | DNA-(apurinic or apyrimidinic site) lyase | 82.58% | 91.11% |
| CHEMBL5845 | P23415 | Glycine receptor subunit alpha-1 | 82.41% | 90.71% |
| CHEMBL340 | P08684 | Cytochrome P450 3A4 | 82.20% | 91.19% |
| CHEMBL2111367 | P27986 | PI3-kinase p110-alpha/p85-alpha | 82.13% | 94.33% |
| CHEMBL3392948 | Q9NP59 | Solute carrier family 40 member 1 | 81.99% | 95.00% |
| CHEMBL4478 | Q00975 | Voltage-gated N-type calcium channel alpha-1B subunit | 81.30% | 97.14% |
| CHEMBL237 | P41145 | Kappa opioid receptor | 81.19% | 98.10% |
| CHEMBL1873 | P00750 | Tissue-type plasminogen activator | 80.74% | 93.33% |
| CHEMBL4588 | P22894 | Matrix metalloproteinase 8 | 80.14% | 94.66% |
Below are displayed all the plants proven (via scientific papers) to contain this
compound!
To see more specific details click the taxa you are interested in.
To see more specific details click the taxa you are interested in.
| There are no matching plants. |
| PubChem | 139589887 |
| LOTUS | LTS0000231 |
| wikiData | Q105246908 |